CL2015001481A1 - Uso de extracto bacopa monnieri - Google Patents

Uso de extracto bacopa monnieri

Info

Publication number
CL2015001481A1
CL2015001481A1 CL2015001481A CL2015001481A CL2015001481A1 CL 2015001481 A1 CL2015001481 A1 CL 2015001481A1 CL 2015001481 A CL2015001481 A CL 2015001481A CL 2015001481 A CL2015001481 A CL 2015001481A CL 2015001481 A1 CL2015001481 A1 CL 2015001481A1
Authority
CL
Chile
Prior art keywords
bacopa monnieri
extract
monnieri extract
cognitive
bacopa
Prior art date
Application number
CL2015001481A
Other languages
English (en)
Inventor
Andrew Scholey
Con Stough
Original Assignee
Soho Flordis Internat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012905250A external-priority patent/AU2012905250A0/en
Application filed by Soho Flordis Internat Pty Ltd filed Critical Soho Flordis Internat Pty Ltd
Publication of CL2015001481A1 publication Critical patent/CL2015001481A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

MÉTODO PARA MEJORAR/AUMENTAR EL DESEMPEÑO COGNITIVO EN UN HUMANO CON ESTRÉS MENTAL, FATIGA MENTAL Y/O COMPROMISO COGNITIVO, QUE COMPRENDE ADMINISTRACIÓN DE EXTRACTO DE BACOPA MONNIERI; Y USO DEL EXTRACTO PARA PREPARAR MEDICAMENTO.
CL2015001481A 2012-12-03 2015-06-02 Uso de extracto bacopa monnieri CL2015001481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2012905250A AU2012905250A0 (en) 2012-12-03 Uses of Bacopa monnieri extract

Publications (1)

Publication Number Publication Date
CL2015001481A1 true CL2015001481A1 (es) 2015-12-28

Family

ID=50882654

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015001481A CL2015001481A1 (es) 2012-12-03 2015-06-02 Uso de extracto bacopa monnieri

Country Status (16)

Country Link
US (1) US20150306164A1 (es)
EP (1) EP2941262A1 (es)
JP (1) JP2016501235A (es)
KR (1) KR20150103679A (es)
CN (1) CN105283193A (es)
AU (1) AU2013354889B2 (es)
BR (1) BR112015012755A2 (es)
CA (1) CA2893036C (es)
CL (1) CL2015001481A1 (es)
MX (2) MX2015006999A (es)
MY (1) MY174744A (es)
PH (1) PH12015501198A1 (es)
SG (1) SG11201504309XA (es)
TW (1) TWI649090B (es)
WO (1) WO2014085851A1 (es)
ZA (1) ZA201504514B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015014473A1 (de) 2015-11-09 2017-05-11 Dr. Loges + Co. Gmbh Kombination von Bacopa monnieri und Sideritis ssp. zur Prophylaxe von Unruhezuständen und Schlafstörungen
IT202100028997A1 (it) * 2021-11-16 2023-05-16 C I A M S R L Composizioni utili per ridurre il declino cognitivo in animali da compagnia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774590B1 (fr) * 1998-02-12 2001-07-13 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir bacopa monnieri (l.)
JP2003246743A (ja) * 2002-02-22 2003-09-02 Taiyo Kagaku Co Ltd 免疫調節組成物
CN101035594B (zh) * 2004-08-09 2013-10-23 酶学技术有限公司 用于糖尿病患者的食品
WO2006117795A1 (en) * 2005-05-03 2006-11-09 Raju Gokaraju Ganga A process for producing enriched fractions containing upto 100% of bacopasaponins from the plant materials of bacopa species

Also Published As

Publication number Publication date
JP2016501235A (ja) 2016-01-18
CA2893036A1 (en) 2014-06-12
PH12015501198A1 (en) 2015-08-17
TWI649090B (zh) 2019-02-01
KR20150103679A (ko) 2015-09-11
AU2013354889A1 (en) 2015-07-23
AU2013354889B2 (en) 2018-07-19
BR112015012755A2 (pt) 2017-07-11
MY174744A (en) 2020-05-13
MX2015006999A (es) 2016-02-25
TW201427678A (zh) 2014-07-16
MX2020012953A (es) 2021-02-16
EP2941262A1 (en) 2015-11-11
WO2014085851A1 (en) 2014-06-12
CN105283193A (zh) 2016-01-27
US20150306164A1 (en) 2015-10-29
ZA201504514B (en) 2022-05-25
CA2893036C (en) 2021-10-26
SG11201504309XA (en) 2015-06-29

Similar Documents

Publication Publication Date Title
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
NI201600071A (es) Compuestos de inhibidor de autotaxina
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
CL2016002971A1 (es) Combinación.
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112014032990A2 (pt) seringa
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
EA201500934A1 (ru) Кардио- и нефропротективная противодиабетическая терапия
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
AR125920A2 (es) Composiciones que comprenden vortioxetina y donepezil
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
CO2017002472A2 (es) Formulación de acetato de abiraterona
AU367163S (en) Blood pressure monitor
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
AU367139S (en) Blood pressure monitor
PE20151435A1 (es) Laquinimod para reducir el dano talamico en la esclerosis multiple
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
ECSP16061208A (es) Quinazolin-thf-aminas como inhibidores de pde1